📢 The World Health Organization's first-ever guidance for best practices for #clinicaltrials is a major step towards better and safer treatments. The key aspects of this new guidance will be presented at a global event on 13 December from 14:00 CET. Register for the Zoom stream 👉🏾https://lnkd.in/efuWt223 Learn more about the guidance 👇🏼 The Global Health Network, NIHR (National Institute for Health and Care Research), Global Health EDCTP3
Ecraid
Ziekenhuizen en gezondheidszorg
Ecraid advances clinical research in the field of infectious diseases.
Over ons
The European Clinical Research Alliance for Infectious Diseases (Ecraid) is a not-for profit foundation that advances clinical research in the field of infectious diseases by establishing a long-term, financially self-sustainable, clinical research network in Europe. Headquartered in Utrecht, the Netherlands, Ecraid is the first network of its kind in Europe to offer a single point of access to a pan-European clinical research network for infectious diseases and spans 1,100 clinical sites and 900 laboratories across 42 countries. For more information, please visit www.ecraid.eu.
- Website
-
www.ecraid.eu
Externe link voor Ecraid
- Branche
- Ziekenhuizen en gezondheidszorg
- Bedrijfsgrootte
- 201 - 500 medewerkers
- Hoofdkantoor
- Utrecht
- Type
- Non-profit
- Opgericht
- 2021
- Specialismen
- Clinical research network, Adaptive platform trials, Infectious diseases en Clinical trials
Locaties
-
Primair
Archimedeslaan 6
Provinciehuis
Utrecht, 3584 BA, NL
Medewerkers van Ecraid
-
Nils Visser
Resultaat gerichte Director of Operations | LEAN 6ẟ Continuous Improvement Manager | Het LEAN uitvoeren van projecten als Project Director
-
Jan Peter van Suchtelen
JPS legal bv
-
Marko Markov
Communications officer at Ecraid
-
René Bastiaans
Being the difference. Thinking contra clockwise. Unlockling hidden potential. Based on broad experience and letting the creative mind do its thing…
Updates
-
Ecraid heeft dit gerepost
Get key insights into ongoing therapeutic research on COVID-19 by reading this 3-minute article, which focuses on recent discoveries about Favipavir made by the PRINCIPLE study. 📖 PRINCIPLE is a TCB-affiliated study funded by UK Research and Innovation and the Department of Health and Social Care through the National Institute for Health and Care Research. 💡 ANRS Maladies infectieuses émergentes, Ecraid, ECRIN (European Clinical Research Infrastructure Network),ID-CARE UNIVR, Penta Foundation - Child Health Research, VACCELERATE_EU, Norwegian Institute of Public Health
New Study Results on Favipiravir Unveiled by the PRINCIPLE Trial 👇
CoMeCT project op LinkedIn
-
🙏🏾 Many thanks to all lecturers and participants who joined the Ecraid x ESCMID 'Better Methods' postgrad course in Belgrade! The past three days of knowledge exchange were intense but so rewarding. 🎙️ Stay tuned for insightful interviews with some of the participants. 👉🏼 Discover more training opportunities and existing resources at ecraid.eu/education ESCMID - European Society of Clinical Microbiology and Infectious Diseases, Marc Bonten, Marcela Krůtová, Mariska Leeflang, Mical Paul, Pontus Naucler, Aleksandra Barac, Miranda Hopman, Henri van Werkhoven, Luigia SCUDELLER #clinicalresearch #infectiousdiseases #clinicaltrials #AI #adaptivedesigns #research #methodology #researchmethodology #researchmethods #microbiology #learning
-
🚩 The EU-funded ECRAID-Base project marked a major milestone, having crossed the threshold of 4,000 enrolled patients in the POS-VAP study! 👏🏽 Patient # 4,000 was added by Prof. Jan De Waele's team at UZ Gent in Belgium. A big 'thank you' to them, as well as the study team at Centre d'Investigation Clinique du CHU de Limoges and all the professionals across Europe working on this important study on ventilator-associated pneumonia. Learn more about POS-VAP 👉🏾 https://lnkd.in/eZDgWT97 Ana Hernandez, Audrey Baylet, Marc Bonten, UMC Utrecht, University of Geneva, European Commission #clinicalresearch #clinicaltrials #pandemicpreparedness #pandemics #pneumonia
-
👩🏻🏫 Ecraid x ESCMID's third 'Better Methods' postgrad course kicked off in Belgrade today. Some 40 participants from 15 European countries will learn from leading experts – and each other – during the next three days. 👉🏾 Discover our upcoming educational opportunities and past recordings at ecraid.eu/education ESCMID - European Society of Clinical Microbiology and Infectious Diseases, Henri van Werkhoven, Luigia SCUDELLER, Marc Bonten, Marcela Krůtová, Mariska Leeflang, Mical Paul, Pontus Naucler, Aleksandra Barac #clinicalresearch #infectiousdiseases #clinicaltrials #AI #adaptivedesigns #research #methodology #researchmethodology #researchmethods #microbiology
-
📄 The EPI-Net team published a comprehensive review of the latest data on candidemia and antifungal resistance rates for six pathogens: C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, and C. auris. Check out their blog post 👉🏼 https://lnkd.in/d2CqVfPA Read the full paper 👉🏾 https://lnkd.in/ebbQ7HwM __________ EPI-Net's work is supported by the EU-funded ECRAID-Base project. ID-CARE UNIVR, University of Verona, University of Tuebingen, Karin Odoj, Jacopo GARLASCO, Maria Diletta Pezzani, Cristina Magnabosco, Diego Ortiz, Fabiana Arieti, European Commission
New study from the EPI-Net group on bloodstream infections by fungi of the Candida genus just published! This new piece of research is the output of a thorough work by the Ecraid EPI-NET team, including researchers from University of Verona and University of Tuebingen. Specifically, this study includes a comprehensive review of the latest data on candidemia and antifungal resistance rates for six pathogens: C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, and C. auris. Find out more on our blog below: https://lnkd.in/d2CqVfPA
New study from the EPI-Net group on bloodstream infections by fungi of the Candida genus just published.
id-care.net
-
Are you looking for information on a vaccines or a specific population in Europe? This new #REF platform will help you navigate #regulatory and #ethicalrequirements for #clinicalstudies in Europe 💡
Sailing through regulatory hurdles is recognised as one of the toughest challenges in multinational clinical research – RED (Regulatory and Ethical Database), your central resource for navigating the regulatory & ethical landscape for submitting European clinical studies , is here to clear the path. 🌟 We are excited to unveil RED, our newly updated tool designed to support the European clinical research community with essential resources and guidance. Whether you're planning a multi-country study or expanding an existing project, RED offers precise, up-to-date information to navigate the complexities of clinical study submissions across Europe. ⛵ Discover what RED has to offer: 🔍 Explore the research landscape: access detailed regulatory and ethical submission requirements for medicinal products for human use, medical devices, and other studies across Europe. 📝 Dive into in-depth content: this tool centralises critical data into 750 easily searchable fields, enabling you to find the essential clinical regulatory information quickly and focus on your research question. 💙 Local experts on board: content is regularly updated by professionals to ensure you have the most current data possible, including translations of key regulatory information where necessary. 🌍 As the number of multinational clinical studies grows, so does the need for streamlined tools like RED. It’s designed to meet this demand, helping sponsors and investigators successfully navigate clinical study regulatory submission requirements in Europe . 🔗 Explore RED today: https://red.ecrin.org/en Thank you to our National Partners who actively worked on the Database: CZECRIN, Infrastructure F-CRIN, GreCRIN, HECRIN, HRB National Clinical Trials Office (NCTO), ItaCRIN, KKS-Netzwerk e. V., NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, SLOVACRIN, Spanish Clinical Research Network (SCReN), Swiss Clinical Trial Organisation 👏🏼 #ClinicalResearch #RED #Regulatory #EthicalSumbissions
-
⚙️ The Grant Management team is the backbone of the EU-funded ECRAID-Base consortium. Rachel Vijlbrief tells us about the team’s tasks and challenges, as well as her hopes for the future of European clinical research. Read the interview 👉🏾 https://lnkd.in/exjEdk3R 📸 The team from left to right: Arya Lekshmi Nair, Ram Venkatachalam, and Rachel Vijlbrief. Marc Bonten, European Commission, UMC Utrecht, University of Verona, Erasmus MC, University of Oxford, University of Antwerp, Laboratory of Medical Microbiology, Karolinska Institutet, ECRIN (European Clinical Research Infrastructure Network), Centre d'Investigation Clinique du CHU de Limoges, Penta Foundation - Child Health Research, University of Geneva, University Hospital Heidelberg (UKHD), Amsterdam UMC, FISEVI, INSERM, Intensive Care National Audit & Research Centre (ICNARC), ESCMID - European Society of Clinical Microbiology and Infectious Diseases, European Respiratory Society #clinicalresearch #collaboration #infectiousdiseases #AMR
-
Sarah Walker introduces Module 5 of our Adaptive Clinical Trial Designs series – available for free online. Learn all about platform trials and the PRACTical design, as well as the RECOVERY, REMAP-CAP and NeoSep1 trials. Read more 👉🏼 https://lnkd.in/e7a8cafw __________ This training series is supported by the EU-funded ECRAID-Base project 🇪🇺 Pavel Mozgunov, Thomas Jaki, Lennie Derde, Julia Bielicki, Marlieke De Kraker, UMC Utrecht, University of Oxford, University of Regensburg, University of Cambridge, Nuffield Department of Medicine, MRC Clinical Trials Unit at UCL, University Children's Hospital Basel, St George's, University of London, European Commission, CoMeCT project #clinicalresearch #clinicaltrials #adaptivetrials #research #infectiousdiseases #pandemic #outbreak #covid19
-
👏🏼 Ellie N., Asst. Trial Manager in the POS-ARI-PC team at the Nuffield Department of Primary Care Health Sciences - University of Oxford, presented the study's goals and progress at the 7th International Clinical Trials Methodology Conference in Edinburgh. 🫱🏻🫲🏾 Ellie highlighted the power of collaboration in clinical research in primary care, particularly through international warm-base networks. POS-ARI-PC, part of the EU-funded ECRAID-Base project, aims to establish a multi-country warm-base network for continuous patient recruitment and data capture in primary care. Read more about it 👉🏾 https://lnkd.in/eDepWHq2 Chris Butler, Alike W. van der Velden, University of Oxford, UMC Utrecht, European Commission #primarycare #infectiousdiseases #clinicalresearch #pandemicpreparedness #outbreaks #pandemics #pneumonia #respiratory